Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...
Clinical trial NCT01319565 · COMPLETED
Trial details
- NCT number
- NCT01319565
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-24
- Primary completion
- 2024-09-10
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.